FDA Inspection 1249658 — Anhye Kim, M.D., Ph.D
The FDA completed an inspection of Anhye Kim, M.D., Ph.D on Aug 16, 2024 in Seongnam. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Aug 16, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Seongnam (Korea (the Republic of))
Additional details
Clinical BA/BE